Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Patients With Endometriosis Recurrence With Aromatase Inhibitor (Anastrazole) Plus GnRH-agonist (Luprolide).

NCT01769781 is registered in ClinicalTrials.gov with Centre for Endocrinology and Reproductive Medicine, Italy as lead sponsor.

NCT NCT01769781
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01769781 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Patients With Endometriosis Recurrence With Aromatase Inhibitor (Anastrazole) Plus GnRH-agonist (Luprolide).
Lead sponsor
Centre for Endocrinology and Reproductive Medicine, Italy
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2013
Completion date
July 31, 2015
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometriosis